Standard Biotools (LAB) Gross Margin (2010 - 2026)
Standard Biotools (LAB) posted quarterly Gross Margin of 53.48% for Q1 2026, down 116.0% year-over-year from 334.22% in Q1 2025, and up 11.8% quarter-over-quarter from 47.83% in Q4 2025.
Standard Biotools (LAB) Gross Margin (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Gross Margin for 17 consecutive years, with 53.48% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 116.0% year-over-year to 53.48%; the TTM figure through Mar 2026 stood at 49.62% (down 51.0% YoY), while the FY2025 annual figure was 49.86%, up 54.0% from the prior year.
- Gross Margin rose to 53.48% in Q1 2026 per LAB's latest filing, from 47.83% in the prior quarter.
- Across five years, Gross Margin topped out at 92.73% in Q1 2022 and bottomed at 23.58% in Q2 2022.
- Historically, Gross Margin has averaged 49.19% across 5 years, with a median of 48.51% in 2025.
- On a YoY basis, Gross Margin climbed as much as 2829 bps in 2022 and fell as far as 7022 bps in 2022.
- Standard Biotools' Gross Margin stood at 41.33% in 2022, then grew by 15 bps to 47.39% in 2023, then slipped by 3 bps to 45.84% in 2024, then advanced by 4 bps to 47.83% in 2025, then grew by 12 bps to 53.48% in 2026.
- Business Quant data shows LAB's Gross Margin at 53.48% in Q1 2026, 47.83% in Q4 2025, and 48.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 45.84% |
| 10 | Standard Biotools | 253.41 Mn | -223.31 Mn | 10.54 Mn | 52.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.40% |
| Mar 31, 2026 | 53.48% |
| Dec 31, 2025 | 47.83% |
| Sep 30, 2025 | 48.51% |
| Jun 30, 2025 | 48.84% |
| Mar 31, 2025 | 54.64% |
| Dec 31, 2024 | 45.84% |
| Sep 30, 2024 | 54.90% |
| Jun 30, 2024 | 46.12% |
| Mar 31, 2024 | 53.11% |
| Dec 31, 2023 | 47.39% |
| Sep 30, 2023 | 43.97% |
| Jun 30, 2023 | 49.17% |
| Mar 31, 2023 | 48.89% |
| Dec 31, 2022 | 41.33% |
| Sep 30, 2022 | 35.95% |
| Jun 30, 2022 | 23.58% |
| Mar 31, 2022 | 92.73% |
| Sep 30, 2021 | 59.14% |
| Jun 30, 2021 | 93.80% |